Skip to main content
ArcticZymes Technologies logo

ArcticZymes Technologies — Investor Relations & Filings

Ticker · AZT ISIN · NO0010014632 LEI · 5967007LIEEXZXGR7K47 BR Manufacturing
Open in API
Filings indexed 968 across all filing types
Latest filing 2023-08-17 Interim / Quarterly Rep…
Country NO Norway
Listing BR AZT

About ArcticZymes Technologies

https://arcticzymes.com/

ArcticZymes Technologies is a life sciences company specializing in the development, manufacturing, and commercialization of novel recombinant enzymes. Leveraging over 30 years of expertise, the company discovers and engineers enzymes from cold-adapted Arctic marine organisms. These enzymes are designed to solve specific challenges in molecular applications, demonstrating high efficiency in demanding conditions such as low temperatures and high salinity. The product portfolio, including Salt Active Nucleases (SAN) and Cod Uracil-DNA Glycosylase, serves global partners in molecular diagnostics, gene therapy, vaccine production, and biomanufacturing. All products are manufactured at its ISO 13485 certified facility, ensuring high quality and performance for research and commercial use.

Recent filings

Filing Released Lang Actions
ArcticZymes Technologies ASA Q2 and 6 months 2023 results
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Quarterly Report' and explicitly covers the financial performance (sales, EBITDA, cash flow) and operational review for the 2nd Quarter of 2023 for ArcticZymes Technologies. It contains detailed financial tables, management commentary, and operational updates, fitting the definition of an Interim/Quarterly Report (IR). It is not a mere announcement (RPA) as it contains the full substantive financial data and analysis. Q2 2023
2023-08-17 English
ArcticZymes Technologies ASA Q2 and 6 months 2023 results
Earnings Release Classification · 100% confidence The document explicitly states it reports the "ArcticZymes Technologies ASA Q2 and 6 months 2023 results." It provides key financial highlights (sales, EBITDA, operating expenses, cash flow) for the second quarter and the first six months of 2023. This structure—a summary of period-specific financial performance released shortly after the period ends—is characteristic of an Earnings Release (ER). Although it mentions a presentation and webcast, the core content is the financial summary itself, not just the announcement of the report's availability (which would suggest RPA). Since it is a summary of period results, it fits the Earnings Release (ER) definition best, rather than the comprehensive Interim/Quarterly Report (IR) which usually contains full financial statements. H1 2023
2023-08-17 English
ArcticZymes Technologies ASA Q2 2023 presentation
Investor Presentation Classification · 98% confidence The document is explicitly titled 'Q2 2023 Presentation' and contains an 'Agenda' followed by sections detailing 'Highlights Q2 2023', 'Business Update', 'Financials' (including sales figures, EBITDA, and expense analysis for Q2), and product/audit updates. This structure is characteristic of an Investor Presentation (IP) used to communicate periodic performance highlights, strategy, and operational updates to investors, distinct from a formal regulatory filing like a 10-K or a brief Earnings Release (ER). Since it is a detailed presentation format covering a specific period (Q2 2023), the classification is Investor Presentation (IP).
2023-08-17 English
ArcticZymes Technologies ASA Q2 2023 presentation
Report Publication Announcement Classification · 98% confidence The document text explicitly states it is the 'ArcticZymes Technologies ASA Q2 2023 presentation' and mentions the release of the 'interim report for the second quarter and first 6 months of 2023'. The document is very short (505 characters) and concludes with the statement 'Please find the presentation attached.' This structure—a brief announcement referencing an attached presentation/report for a specific interim period—strongly indicates that this document is an announcement about the publication of the report, rather than the comprehensive report itself (which would be classified as IR). Therefore, the most appropriate classification is Report Publication Announcement (RPA).
2023-08-17 English
ArcticZymes Technologies ASA: Invitation to presentation of Q2 2023 results
Report Publication Announcement Classification · 98% confidence The document is titled "ArcticZymes Technologies ASA: Invitation to presentation of Q2 2023 results" and explicitly states that the company will present its report for Q2 2023 on a specific date (August 17, 2023). It details the time, hosts, and instructions for joining the online presentation and Q&A session. Crucially, it mentions that the actual report will be available on their website from 07:00 a.m. on the same day. Since this document is an invitation/announcement about the upcoming release and presentation of the results, rather than the full results document itself (which would likely be an IR or ER), it fits the definition of a Report Publication Announcement (RPA). The document length is very short (1344 chars), supporting the 'announcement' classification over the full report classification.
2023-08-14 English
ArcticZymes Technologies launches AZtaqT DNA Polymerase
Earnings Release Classification · 99% confidence The document is a short press release dated August 10, 2023, announcing the launch of a new product, AZtaq™ DNA Polymerase, by ArcticZymes Technologies ASA. It details the product's features and strategic importance. This type of announcement, focusing on a specific business event (product launch) rather than comprehensive financial results (ER, IR, 10-K) or management changes (MANG), typically falls under general regulatory announcements or news releases. Since there is no specific category for 'Product Launch Announcement' and it is not a financial report, capital change, or director dealing, the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory/news announcements. Q3 2023
2023-08-10 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.